BGLAF
Price
$10.42
Change
+$0.84 (+8.77%)
Updated
Jul 29 closing price
Capitalization
1.16B
HLUBF
Price
$5.47
Change
-$0.10 (-1.80%)
Updated
Sep 17 closing price
Capitalization
6.79B
Interact to see
Advertisement

BGLAF vs HLUBF

Header iconBGLAF vs HLUBF Comparison
Open Charts BGLAF vs HLUBFBanner chart's image
Biogaia AB
Price$10.42
Change+$0.84 (+8.77%)
Volume$1K
Capitalization1.16B
H. Lundbeck A/S
Price$5.47
Change-$0.10 (-1.80%)
Volume$650
Capitalization6.79B
BGLAF vs HLUBF Comparison Chart in %
Loading...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGLAF vs. HLUBF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and HLUBF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BGLAF: $10.42 vs. HLUBF: $5.47)
Brand notoriety: BGLAF and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BGLAF: 88% vs. HLUBF: 100%
Market capitalization -- BGLAF: $1.16B vs. HLUBF: $6.79B
BGLAF [@Pharmaceuticals: Generic] is valued at $1.16B. HLUBF’s [@Pharmaceuticals: Generic] market capitalization is $6.79B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 1 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • BGLAF’s FA Score: 1 green, 4 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, BGLAF is a better buy in the long-term than HLUBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLUBF’s TA Score shows that 3 TA indicator(s) are bullish.

  • HLUBF’s TA Score: 3 bullish, 3 bearish.

Price Growth

BGLAF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HLUBF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLUBF($6.79B) has a higher market cap than BGLAF($1.16B). BGLAF has higher P/E ratio than HLUBF: BGLAF (34.63) vs HLUBF (9.88). HLUBF YTD gains are higher at: 23.476 vs. BGLAF (8.768). HLUBF has higher annual earnings (EBITDA): 4.82B vs. BGLAF (393M). HLUBF has more cash in the bank: 2.65B vs. BGLAF (622M). HLUBF has higher revenues than BGLAF: HLUBF (23.5B) vs BGLAF (1.44B).
BGLAFHLUBFBGLAF / HLUBF
Capitalization1.16B6.79B17%
EBITDA393M4.82B8%
Gain YTD8.76823.47637%
P/E Ratio34.639.88351%
Revenue1.44B23.5B6%
Total Cash622M2.65B23%
Total DebtN/A13.6B-
TECHNICAL ANALYSIS
Technical Analysis
BGLAFHLUBF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
37%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
27%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
30%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
38%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
34%
View a ticker or compare two or three
Interact to see
Advertisement
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVTIX11.480.11
+0.97%
Transamerica Mid Cap Value Opps I
ATGYX49.720.42
+0.85%
Cantor Fitzgerald Equity Opp Inst
PBFDX36.580.15
+0.41%
Payson Total Return
GAOAX22.170.09
+0.41%
JPMorgan Global Allocation A
JHQRX34.660.03
+0.08%
JPMorgan Hedged Equity R6

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
19%
Poorly correlated
N/A
HLNCF - HLUBF
7%
Poorly correlated
-3.57%
ESAIY - HLUBF
5%
Poorly correlated
-0.23%
EAPIF - HLUBF
0%
Poorly correlated
N/A
BGLAF - HLUBF
-0%
Poorly correlated
N/A
More